Georgia Valsami

Georgia Valsami is a **Professor of Biopharmaceutics-Pharmacokinetics** at the **Department of Pharmacy, National and Kapodistrian University of Athens (NKUoA)**. Her research focuses on drug delivery systems, cyclodextrin complexes, pharmacokinetics, and preclinical/clinical drug evaluation. She holds roles including Director of the Section of Pharmaceutical Technology and President of the Internal Evaluation Committee of the Department of Pharmacy.

**Education**: B Pharm (Aristotle University of Thessaloniki, 1984), PhD in Biopharmaceutics (NKUoA, 1990). Postdoctoral training (1991-1999) in Biopharmaceutics-Pharmacokinetics at NKUoA.

**Research Interests**: Drug-protein binding, cyclodextrin-mediated solubility enhancement, novel dosage forms (e.g., nasal films, hydrogels), pharmacokinetic modeling, and anti-inflammatory/antioxidant drug development. Her work spans cardiovascular, neurodegenerative, and hepatic disorders.

**Publications**: Over 150 peer-reviewed articles, with recent emphasis on nose-to-brain drug delivery, cyclodextrin complexes, and pharmacokinetic modeling. Key topics include quercetin’s anti-NAFLD effects, silibinin’s hepatoprotective properties, and flurbiprofen nasal formulations for Alzheimer’s.

**Awards**: Recipient of the 3-year Hellenic State Scholarship Foundation (IKY) PhD scholarship (1987-1990).

**Professional Roles**: Member of the European Medicines Agency (EMA)-NOM committee, Scientific Board for Drug Approvals, and Controlled Release Society-Greek Chapter President (2001-2006, 2011).

**Labs/Teams**: Leads the Pharmaceutical Technology Section at NKUoA, focusing on cutting-edge drug delivery systems and translational research.